General Information
Revision date
2018-05-06
Product name
LYNPARZA CAPSULES
Product Synonyms
AZD2281 Capsules
CAS No.
763113-22-0
1.2.1 Relevant identified uses
Potential anti-cancer agent
supplier name
ASTRAZENECA PTY LTD
Icons in SDS
Company Information
company name
ASTRAZENECA PTY LTD
e-mail address of the competent person responsible for the Safety Data Sheet
SafetyDataSheets.AlderleyPark@astrazeneca.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360, H372, H412
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
2.1 Classification of the substance or mixture
Reproductive toxicity Category 1B Specific target organ toxicity - Category 1 (Bone marrow, lymph node, spleen, Liver, Gastro- repeated exposure (Oral) intestinal system) Chronic aquatic toxicity Category 3
Signal word
Danger
Hazard statements
H360 May damage fertility or the unborn child. H372 Causes damage to organs (Bone marrow, lymph node, spleen, Liver, Gastro-intestinal system) through prolonged or repeated exposure if swallowed. H412 Harmful to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
Olaparib
Other hazards which do not result in classification
Evidence of genotoxicity and should be treated with caution. May cause reduced resistance to infection and increased risk of bleeding. May form explosible dust-air mixture if dispersed. See Section 11.
